Background: The effectiveness of antisense oligodeoxynucleotides for in vitro and in vivo studies is limited by a low efficiency of cellular uptake and instability due to degradation by nucleases. To overcome some of these problems, we recently developed a transfer method that utilizes inactivated Sendai virus (hemagglutinating virus of Japan [HVJ]) complexed with liposomes to deliver antisense oligodeoxynucleotides. In this study, we compared the effectiveness of the HVJ-liposome method versus a cationic liposome method versus passive uptake to deliver antisense oligodeoxynucleotides against basic fibroblast growth factor on angiotensin (Ang) II-induced rat vascular smooth muscle cell growth.
Methods and Results: Twenty to twenty-eight hours after transfection, antisense fibroblast growth factor oligodeoxynucleotides introduced by passive uptake and HVJ-liposome method decreased basal DNA synthesis significantly as compared to the sense, control, and scrambled oligodeoxynucleotides groups; however, 60-68 hours after transfection, only anti sense fibroblast growth factor oligodeoxynucleotides transduced by the HVJ-liposome method resulted in a significant inhibition of DNA synthesis under basal and Ang II-(10-6M) stimulated conditions. The IC25 of oligodeoxynucleotides assessed by the inhibition of thymidine incorporation was significantly lower using the HVJ-liposome method than those using the other transfer methods. To clarify the mechanisms of cellular uptake of olibodeoxynucleotides with the HVJ-liposome method, we studied the cellular fate of fluo rescein isothiocyanate (FITC)-labeled oligodeoxynucleotides FITC-oligodeoxynucleotides was localized in nuclei at 5 minutes after transfection with the HVJ-liposome method. In contrast, FITC-oligodeoxynucleotides introduced by passive uptake was detected in nonnu clear cellular compartments, possibly endosomes, but not the nuclei. Cellular fluorescence of oligodeoxynucleotides introduced by passive uptake disappeared within 24 hours, while that introduced by the HVJ-liposome method could be observed up to 72 hours.
Conclusion: These results demonstrate that the HVJ-liposome transfer enhanced the effec tiveness of AS-fibroblast growth factor via its specific molecular mechanisms of transfer.
Marcus-Sekura CJTechniques for using antisense oligodeoxynucleotides to study gene expression. Anal Biochem172:289, 1988
2.
Stein CA, Cohen JSOligodeoxynucleotides as inhibitors of gene expression: a review. Cancer Res48:2659, 1988
3.
Agrawal SJ, Temsamani J., Tang Y.Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotides phosphorothioates in mice. Proc Natl Acad Sci U S A88: 7595, 1991
4.
Loke SL, Stein C., Zhang X., Avigan M., Cohen J., Neckers LMDelivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis. Curr Top Microbiol Immunol141:282, 1988
5.
Kato K., Nakanishi Y., Kaneda Y., Uchida T., Okada Y.Expression of hepatitis B virus surface antigen in adult rat liver. J Biol Chem266:3361, 1991
6.
Kaneda Y., Iwai K., Uchida T.Introduction and expression of the human insulin gene in adult rat liver. J Biol Chem264:12126, 1989
7.
Okada Y.Analysis of giant polynuclear cell formation caused by HVJ virus from Ehrlich's ascites tumor cells: I microscopic observation of giant polynuclear cell formation . Exp Cell Res26:98, 1962
8.
Okada Y., Koseki I., Kim J., Hashimoto T., Kanno Y., Matsui Y.Modification of cell membranes with viral envelopes during fusion of cells with HVJ (Sendai virus). Exp Cell Res93:368, 1975
9.
Tanaka K., Sekiguchi M., Okada Y.Restoration of ultraviolet-induced unscheduled DNA synthesis of xeroderma pigmentosum cells by the concomitant treatment with bacteriophage T4 endonuclease V and HVJ (Sendai virus). Proc Natl Acad Sci U S A72:4071, 1975
10.
Furusawa M. , Nishimura T., Yamaizumi M., Okada Y.Injection of foreign substances into single cells by cell fusion. Nature249:449, 1974
11.
Morishita R. , Gibbons GH, Ellison KE, Nakajima N., Zhang L., Kaneda Y., Ogihara T., Dzau VJSingle intraluminal administration of antisense cdc 2 kinase and proliferating cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci U S A90:8474, 1993
12.
Morishita R. , Gibbons GH, Ellison KE, Nakajima N., Leyen Hvd, Zhang L., Kaneda Y., Ogihara T., Dzau VJIntimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest93:1458, 1994
13.
Owens GK, Thompson LGExpression of smooth muscle specific isoactin in cultured smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol102:343, 1986
14.
Morrison RSSuppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem266:728, 1991
15.
Itoh H., Mukoyama M., Pratt RE, Dzau VJSpecific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotides. Biochem Biophys Res Commun188:1205, 1992
16.
Itoh H., Mukoyama M., Pratt RE, Dzau VJMultiple autocrine growth factors modulate vascular smooth muscle cells growth response to angiotensin II. J Clin Invest91: 2268, 1993
17.
Mossman T.Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxity assays. J Immunol Methods65:55, 1986
18.
Morishita R. , Gibbons GH, Kaneda Y., Ogihara T., Dzau VJNovel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest91:2580, 1993
19.
Morishita R. , Gibbons GH, Kaneda Y., Ogihara T., Dzau VJNovel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells. Hypertension21:894, 1993
20.
Leonetti JPMechti N.Degols G., Gagnor C., Lebleu B.Intracellular distribution of microinjected antisense oligonucleotides. Proc Natl Acad Sci U S A88:2702, 1991
21.
Busen W.Purification, subunit structure, and serological analysis of calf thymus ribonuclease Hl. J Biol Chem255: 9434, 1980
22.
Spiller DG, Tidd DMThe uptake kinetics of chimeric oligodeoxynucleotides analogues in human leukemia MOLT-4 cells. Anticancer Drug Des7:115, 1992
Akhtar S., Juliano RLCellular uptake and intracellular fate of antisense oligonucleotides. Trends Cell Biol2:139, 1992
25.
Gibbons GHPratt RE, Dzau VJVascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest90:456, 1992
26.
Lindner V., Reidy MAProliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A88:3739, 1991
